Literature DB >> 3292008

N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs.

J D Leander1, R R Lawson, P L Ornstein, D M Zimmerman.   

Abstract

N-Methyl-D-aspartic acid (NMDA) produced a dose-related increase in lethality in mice, with 200 mg/kg (i.p.) effecting 100% lethality. Upon daily dosing, acutely sublethal doses of NMDA produced deaths. This NMDA-induced lethality was stereoselective; N-methyl-L-aspartic acid had no effects at doses as high as 400 mg/kg. Moderate doses of phencyclidine (PCP) and drugs having PCP-like behavioral effects blocked the NMDA-induced lethality. Other classes of psychoactive drugs, including opioids, anticonvulsants and antipsychotics, were ineffective in preventing NMDA-induced lethality. The potency of PCP-like drugs to block the NMDA-induced lethality correlates highly with the dose necessary to produce PCP-like catalepsy and PCP-like discrimination in pigeons. These data support the hypothesis that PCP-like drugs produce many of their effects by impairing the normal functioning of the NMDA-defined excitatory neurotransmitter receptor in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292008     DOI: 10.1016/0006-8993(88)91107-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Achyranthes aspera Attenuates epilepsy in experimental animals: possible involvement of GABAergic mechanism.

Authors:  Gollapalle Lakshminarayanashastry Viswanatha; Marikunte V Venkataranganna; Nunna Bheema Lingeswara Prasad; Ashok Godavarthi
Journal:  Metab Brain Dis       Date:  2017-03-06       Impact factor: 3.584

2.  Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist.

Authors:  D D Schoepp; P L Ornstein; C R Salhoff; J D Leander
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Comparative analysis of seizures induced by intracerebroventricular administration of NMDA, kainate and quisqualate in mice.

Authors:  C Mathis; A Ungerer
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

4.  Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants.

Authors:  J L Moreau; L Pieri; B Prud'hon
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

5.  Transient Adenosine Release Is Modulated by NMDA and GABAB Receptors.

Authors:  Michael D Nguyen; Ying Wang; Mallikarjunarao Ganesana; B Jill Venton
Journal:  ACS Chem Neurosci       Date:  2017-01-30       Impact factor: 4.418

6.  Anticonvulsant activity of fraction isolated from ethanolic extract of heartwood of Cedrus deodara.

Authors:  Daniel Dhayabaran; Ebinezar Jeyaseeli Florance; Krishnadas Nandakumar; Alagarsamy Shanmugarathinam; Ayarivan Puratchikody
Journal:  J Nat Med       Date:  2014-04       Impact factor: 2.343

7.  In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channels.

Authors:  M Wienrich; M Brenner; W Löscher; R Palluk; M Pieper; H Potschka; T Weiser
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

8.  Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.

Authors:  L Singh; R J Oles; M D Tricklebank
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).

Authors:  L Singh; E H Wong; A C Kesingland; M D Tricklebank
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

10.  Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice.

Authors:  D K Von Lubitz; I A Paul; M Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1993-11-16       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.